Elsevier

Fertility and Sterility

Volume 70, Issue 2, August 1998, Pages 274-278
Fertility and Sterility

Reproductive Indocrinology
Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama

Presented in part at the 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati, Ohio, October 18–22, 1997.
https://doi.org/10.1016/S0015-0282(98)00141-1Get rights and content
Under an Elsevier user license
open archive

Abstract

Objective: To determine the prevalence of idiopathic hirsutism among a population of consecutive hirsute patients.

Design: Prospective cohort study.

Setting: University-based clinic.

Patient(s): Premenopausal women with a complaint of hirsutism who were not receiving hormonal therapy.

Intervention(s): Evaluations for total and free testosterone, (T), 17-hydroxyprogesterone (17-HP), and DHEAS serum levels.

Main Outcome Measure(s): Ovulatory function in women with cycles of ≤35 days in length was assessed with a basal body temperature (BBT) calendar and day 22–24 progesterone levels.

Result(s): Of 132 consecutive hirsute women studied, 68 had cycles of >35 days in length. Of the remaining 64 patients, 25 also had oligo/anovulation by BBT and day 22–24 progesterone level. Of the 39 patients with hirsutism and regular ovulatory function, 22 had total and free T and DHEAS levels within normal limits.

Conclusion(s): If idiopathic hirsutism is defined by the presence of hirsutism, regular ovulation, and normal androgen levels, only 17% of consecutive hirsute patients can be diagnosed with the disorder. Alternatively, if idiopathic hirsutism is based solely on the presence of hirsutism and regular ovulation, regardless of androgen levels, then 29% of the total hirsute population can be considered as having idiopathic hirsutism. Importantly, 40% of hirsute patients with a history of “regular cycles” were actually oligo/anovulatory, indicating the need to objectively assess ovulatory function in such patients.

Keywords

Hirsutism
androgens
polycystic ovary syndrome
ovulatory dysfunction

Cited by (0)

Supported in part by grant RO1-HD29364 from the National Institutes of Health, Bethesda, Maryland (R.A.).

Department of Obstetrics and Gynecology.

Department of Medicine.

Present address: Ministerio de Salud Publica del Ecuador, Quito, Ecuador.